Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, shared a post on LinkedIn:
“With the adjustment of medical funding, we hope that the authorities will fulfill their promise to use the funds saved every year to support severe patients with rare diseases, cancer, and other serious diseases, so that everyone can take medication ‘quickly and accurately’, and truly realize the heart – warming goal of ‘serious illness does not lead to poverty’.
What is even more gratifying is that the ‘Office for the Introduction of Innovative Drugs and Medical Devices’ is about to actively make efforts, from passive waiting in the past to actively advancing, which makes the industry and the public full of expectations!”
Read Norman Ng’s earlier post on OncoDaily.